Ian Lorimer
Impact in
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Oncology top 2%
- HER2/EGFR in Cancer Research
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
Papers in
-
- Glycosylation and Glycoproteins Research 2
-
- Monoclonal and Polyclonal Antibodies Research 5
- Radiomics and Machine Learning in Medical Imaging 3
- Co-authors
- Ming‐Sound Tsao (5 shared papers)Manijeh Daneshmand (7 shared papers)Frances A. Shepherd (4 shared papers)Keyue Ding (3 shared papers)Lesley Seymour (3 shared papers)Akira Sakurada (2 shared papers)Jeremy A. Squire (2 shared papers)Jean-Claude Cutz (2 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)Neuro-Oncology (1 paper)Clinical & Experimental Metastasis (1 paper)PLoS ONE (1 paper)Nucleic Acids Research (1 paper)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Ian Lorimer
28 papers receiving 2.6k citations
Ian Lorimer's Hit Papers
Peers
Comparison fields: 5 of 91
- Pulmonary and Respiratory Medicine 1.4k
- Oncology 1.1k
- Cancer Research 355
- Molecular Biology 753
- Radiology, Nuclear Medicine and Imaging 212
Countries citing papers authored by Ian Lorimer
This map shows the geographic impact of Ian Lorimer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian Lorimer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian Lorimer more than expected).
Fields of papers citing papers by Ian Lorimer
This network shows the impact of papers produced by Ian Lorimer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian Lorimer. The network helps show where Ian Lorimer may publish in the future.
Co-authors
The 25 scholars most cited alongside Ian Lorimer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Erlotinib in Lung Cancer — Molecular and Clinical Predictors of Outcome Hit paper breakdown → | 2005 | 1485 |
| 2 | 2013 | 238 | |
| 3 | 2007 | 211 | |
| 4 | 1996 | 112 | |
| 5 | 2011 | 99 | |
| 6 | Immunotoxins that target an oncogenic mutant epidermal growth factor receptor expressed in human tumors. | 1995 | 60 |
| 7 | 2010 | 58 | |
| 8 | 2011 | 50 | |
| 9 | 1995 | 49 | |
| 10 | Regional treatment of epidermal growth factor receptor vIII-expressing neoplastic meningitis with a single-chain immunotoxin, MR-1. | 1999 | 49 |
| 11 | 2005 | 35 | |
| 12 | 2010 | 34 | |
| 13 | 2013 | 31 | |
| 14 | 1994 | 25 | |
| 15 | 1985 | 19 | |
| 16 | 2021 | 18 | |
| 17 | 1994 | 18 | |
| 18 | 2005 | 16 | |
| 19 | 2001 | 11 | |
| 20 | 1999 | 8 |
About Ian Lorimer
Ian Lorimer is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine, Immunology and Genetics, having authored 28 papers that have together received 2.7k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (5 papers), Lung Cancer Treatments and Mutations (4 papers), Glioma Diagnosis and Treatment (4 papers), Cancer Genomics and Diagnostics (3 papers), Radiomics and Machine Learning in Medical Imaging (3 papers), Toxin Mechanisms and Immunotoxins (3 papers), Glycosylation and Glycoproteins Research (2 papers) and Breast Cancer Treatment Studies (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.4k citations), Oncology (1.1k citations), Cancer Research (355 citations), Molecular Biology (753 citations) and Radiology, Nuclear Medicine and Imaging (212 citations). Ian Lorimer has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Ming‐Sound Tsao, Manijeh Daneshmand, Frances A. Shepherd, Keyue Ding, Lesley Seymour, Akira Sakurada, Jeremy A. Squire, Jean-Claude Cutz, Suzanne Kamel‐Reid and Frank C. Richardson. Their work appears in journals such as Journal of Clinical Oncology, Neuro-Oncology, Clinical & Experimental Metastasis, PLoS ONE and Nucleic Acids Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.